Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-31 @ 4:20 AM
Study NCT ID:
NCT05027204
Status:
UNKNOWN
Last Update Posted:
2022-10-13
First Post:
2021-08-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Docetaxel for Injection (Albumin-bound) in Combination With Nivolumab in Patients With Head and Neck (SCCHN)
Sponsor:
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2021-08-19
First Submit QC Date:
None
Study First Post Date:
2021-08-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-12
Last Update Post Date:
2022-10-13
Last Update Post Date Type:
ACTUAL